INTERACTION OF SCH-23390, A D-1-SELECTIVE ANTAGONIST, WITH THE ANTERIOR-PITUITARY D-2 RECEPTORS AND PROLACTIN SECRETION IN THE RAT

被引：43

作者：

APUD, JA ^{[1
]}

MASOTTO, C ^{[1
]}

ONGINI, E ^{[1
]}

RACAGNI, G ^{[1
]}

机构：

[1] UNIV MILAN, CTR NEUROPHARMACOL, INST PHARMACOL & PHARMACOGNOSY, VIA BALZARETTI 9, I-20133 MILAN, ITALY

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1985年 / 112卷 / 02期

关键词：

D O I：

10.1016/0014-2999(85)90495-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：187 / 193

页数：7

共 50 条

[1] INHIBITION OF DRINKING BY NALTREXONE IN THE RAT - INTERACTION WITH THE DOPAMINE D-1 ANTAGONIST SCH-23390 AND THE D-2 ANTAGONIST SULPIRIDE
UKAI, M
NAKAYAMA, S
KAMEYAMA, T
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) : 651 - 655
[2] EFFECTS ON FEEDING RESPONSES OF THE SELECTIVE DOPAMINE D-1 ANTAGONIST SCH-23390 AND THE SELECTIVE D-2 ANTAGONIST YM-09151-2 IN THE RAT
CLIFTON, PG
RUSK, IN
COOPER, SJ
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1989, 575 : 602 - 605
[3] EFFECTS ON FEEDING RESPONSES OF THE SELECTIVE DOPAMINE D-1 ANTAGONIST SCH-23390 AND THE SELECTIVE D-2 ANTAGONIST YM-09151-2 IN THE RAT
CLIFTON, PG
RUSK, IN
COOPER, SJ
[J]. PSYCHOBIOLOGY OF HUMAN EATING DISORDERS: PRECLINICAL AND CLINICAL PERSPECTIVES, 1989, 575 : 602 - 605
[4] SCH-23390 - THE 1ST SELECTIVE DOPAMINE D-1 ANTAGONIST
HYTTEL, J
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) : 153 - 154
[5] ATTENUATION OF THE LOCOMOTOR-SENSITIZING EFFECTS OF THE D-2 DOPAMINE AGONIST BROMOCRIPTINE BY EITHER THE D-1 ANTAGONIST SCH-23390 OR THE D-2 ANTAGONIST RACLOPRIDE
WISE, RA
CARLEZON, WA
[J]. SYNAPSE, 1994, 17 (03) : 155 - 159
[6] SCH-23390 - A SELECTIVE-D1 DOPAMINE ANTAGONIST WITH POTENT-D2 BEHAVIORAL ACTIONS
MAILMAN, RB
SCHULZ, DW
LEWIS, MH
STAPLES, L
ROLLEMA, H
DEHAVEN, DL
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 101 (1-2) : 159 - 160
[7] DOPAMINE-D2 RECEPTORS AND SCH-23390 TREATMENT
ROONEY, KF
SEWELL, RDE
SPENCER, PSJ
STOLZ, JF
[J]. LANCET, 1986, 2 (8506): : 578 - 578
[8] COMPARISON OF THE EFFECTS OF NEUROLEPTICS AND A SELECTIVE D-1 ANTAGONIST, SCH23390, ON D-1 AND D-2 DOPAMINE-RECEPTORS
PLANTJE, JF
DAUS, FJ
HANSEN, HA
STOOF, JC
[J]. PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1984, 6 (01) : 55 - 55
[9] ABSENCE OF [H-3] SCH-23390 SPECIFIC BINDING-SITES IN ANTERIOR-PITUITARY - DISSOCIATION FROM EFFECTS ON PROLACTIN SECRETION
ROVESCALLI, AC
BRUNELLO, N
MONOPOLI, A
ONGINI, E
RACAGNI, G
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 135 (02) : 129 - 136
[10] CHARACTERIZATION OF A RAT-LIVER GLUCURONOSYLTRANSFERASE THAT GLUCURONIDATES THE SELECTIVE-D1 ANTAGONIST, SCH-23390, AND OTHER BENZAZEPINES
TEDFORD, CE
RUPERTO, VB
BARNETT, A
[J]. DRUG METABOLISM AND DISPOSITION, 1991, 19 (06) : 1152 - 1159

← 1 2 3 4 5 →